Cargando…
1700. Posaconazole-Induced Excess Mineralocorticoid Syndrome with Hypertension, Hypokalemia, and Inhibition of 11-b-hydroxylase in Pediatric Patients
BACKGROUND: Posaconazole is a potent broad spectrum mould-active triazole that is increasingly used in children for treatment of aspergillosis, mucormycosis, and endemic mycoses. Although posaconazole has a favorable safety profile in pediatric patients, we recently observed an excess mineralocortic...
Autores principales: | Chen, Tempe K, Batra, Jagmohan S, Chawla, Rachit, Quanquin, Natalie, Michalik, David E, Sharma, Kavita, Farkas-Skiles, Cristina, Patel, Bhavita, Casillas, Jacqueline, Patel, Ramesh, Chung, Jong, Kadapakkam, Meena, Okada, Maki, Walsh, Thomas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676965/ http://dx.doi.org/10.1093/ofid/ofad500.1533 |
Ejemplares similares
-
Posaconazole-induced hypertension and hypokalemia due to inhibition of the 11β-hydroxylase enzyme
por: Barton, Kevin, et al.
Publicado: (2018) -
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases
por: Chen, Tempe K, et al.
Publicado: (2022) -
Mineralocorticoid hypertension and hypokalaemia induced by posaconazole
por: Boughton, Charlotte, et al.
Publicado: (2018) -
Posaconazole-Induced Apparent Mineralocorticoid Excess
por: Pandit, Amar, et al.
Publicado: (2020) -
Posaconazole-Induced Hypertension and Hypokalemia: Mechanistic Evaluation
por: Thompson, George R, et al.
Publicado: (2017)